Septerna

septerna.com

Septerna is a clinical-stage biotechnology company pioneering GPCR drug discovery through its proprietary Native Complex Platform™, focusing on developing oral small molecule therapies for endocrinology, immunology, inflammation, and metabolic diseases. The company aims to unlock the potential of difficult-to-drug GPCRs, advancing a deep pipeline of drug candidates to address significant unmet medical needs. With a world-class team of experts, Septerna is positioned to make a substantial impact in the biotechnology sector, leveraging cutting-edge science and collaboration to drive innovation and results.